Location
France, Europe
Cheque size
$100K - $5M
Investment Stage
Seed
Series A
Focus Areas
BioTech
Pharmaceuticals
About Investor
Marianne Bjørdal is a Partner at 3B Future Health Ventures, where she leads seed and Series A investments of $100 K–$5 M into pharmaceuticals, biotech and therapeutics companies. She is based in Paris, France. Prior to joining 3B Future Health in 2018 and being promoted to Partner in 2022, she spent over 15 years as a researcher at the French National Centre for Scientific Research (CNRS), was a Marie Curie Early-Stage Researcher, and holds an M.Sc. in Molecular Biology, a Ph.D. in Molecular and Cellular Biology, and an MBA.
Previous investments
Epsilogen
16M |2024
41M |2022
Sibylla Biotech
23M |2022
GenEp
1M |2021
Similar Investors
JG
Joaquin Gomez
United Kingdom, Europe
$50K - $1M
Pre Seed
,Seed
,WT
William Tunstall-Pedoe
United Kingdom, Europe
$10K - $500K
Pre Seed
,Seed
,CJ
Christoph Janz
Germany, Europe
$580K - $3.5M
Pre Seed
,Seed
,IT
Igor Tikhturov
United Kingdom, Europe
$100K - $5M
Pre Seed
,Seed
,EV
Eze Vidra
United Kingdom, Europe
$300K - $1.5M
Pre Seed
,Seed
,PL
Pierre-Eric Leibovici
France, Europe
$500K - $10M
Seed
,Series A
,Is this Your Profile?
If you have any updates, please fill out our form.